IL-6 dysregulation originates in dendritic cells and mediates graft-versus-host disease via classical signaling-Reference-Cited by-同舟云学术

IL-6 dysregulation originates in dendritic cells and mediates graft-versus-host disease via classical signaling

Published:2019-12-05 Issue:23 Volume:134 Page:2092-2106
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Wilkinson Andrew N.¹²^ORCID,Chang Karshing¹,Kuns Rachel D.¹,Henden Andrea S.¹²³^ORCID,Minnie Simone A.¹²,Ensbey Kathleen S.¹,Clouston Andrew D.⁴,Zhang Ping¹^ORCID,Koyama Motoko¹⁵,Hidalgo Juan⁶⁷^ORCID,Rose-John Stefan⁸^ORCID,Varelias Antiopi¹²^ORCID,Vuckovic Slavica¹²,Gartlan Kate H.¹²⁵^ORCID,Hill Geoffrey R.¹³⁵⁹

Affiliation:

1. QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia;

2. Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia;

3. Royal Brisbane and Women’s Hospital, Brisbane, QLD, Australia;

4. Envoi Specialist Pathologists, Brisbane, QLD, Australia;

5. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;

6. Animal Physiology Unit, Department of Cellular Biology, Physiology and Immunology, Faculty of Biosciences, and

7. Institute of Neurosciences, Universitat Autònoma de Barcelona, Bellaterra, Spain;

8. Institute of Biochemistry, Christian-Albrechts-Universität zu Kiel, Kiel, Germany; and

9. Division of Medical Oncology, University of Washington, Seattle, WA

Abstract

Key Points DCs are the principal source of IL-6 dysregulation after alloSCT. IL-6–dependent GVHD is driven by classical signaling of IL-6R on donor T cells but is regulated by trans signaling.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/134/23/2092/1545370/bloodbld2019000396.pdf

Reference73 articles.

1. Graft-versus-host disease;Shlomchik;Nat Rev Immunol,2007

2. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines;Hill;Blood,1997

3. Cytokines in graft-versus-host disease;Henden;J Immunol,2015

4. The role of pattern-recognition receptors in graft-versus-host disease and graft-versus-leukemia after allogeneic stem cell transplantation;Heidegger;Front Immunol,2014

5. IL-6 as a keystone cytokine in health and disease [published correction appears in Nat Imunol. 2017;18(11):1271];Hunter;Nat Immunol,2015

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of steroid-refractory graft versus host disease in children;Frontiers in Transplantation;2023-09-15

2. Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis;TRANSPL CELL THER;2023

3. Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis;Transplantation and Cellular Therapy;2023-08

4. The significance of M1‐polarized CD163+ macrophages in acute graft‐versus‐host disease (GVHD): Possible mechanisms of GVHD in the development of skin lesions;Journal of Cutaneous Immunology and Allergy;2023-03-27

5. USP11 plays a critical role in the onset and progression of acute graft-versus-host disease：Novel target for precision therapeutics;Pharmacological Research;2023-03